Discover a groundbreaking webinar delving into multifaceted strategies aimed at enhancing diversity within the realm of Alzheimer’s disease (AD) research. Addressing significant challenges rooted in the widespread lack of trust within diverse patient populations, the featured speakers forge collaborative efforts with advocacy groups, who serve as crucial bridges between the healthcare system and the communities they serve. Going beyond conventional screening practices, these strategies also involve extensive examination of medical records and employ a diverse array of tactics to identify potential patients who might otherwise go unnoticed.
Innovation plays a pivotal role in not only tracking and reporting progress but also in educating these underrepresented patient populations. This webinar involves the open exchange of ideas, acknowledging that the path to solutions is neither instantaneous nor linear. Ultimately, this comprehensive approach encapsulates the principles of diversity, equity and inclusion (DE&I), serving as a model for advancing equitable access to Alzheimer’s research.
Join this webinar in shaping a future where diversity is the cornerstone of progress in Alzheimer’s research.
Katie King, Associate Director, Patient Engagement, Biogen
A seasoned professional with a decade of experience in the pharmaceutical industry, who currently serves as the Associate Director and Development Unit Lead of Alzheimer’s Disease and Dementias on Biogen’s Patient Centricity and Engagement team. With a strong commitment to making an impact, Katie has been at the forefront of many initiatives in the challenging and critical field of Alzheimer’s Disease throughout her career, spearheading efforts to enhance patient engagement and promote health equity. Her wealth of experience and leadership have been instrumental in driving advancements in the pursuit of innovative solutions.
Zack Metcalf, Senior Director, Global Business Solutions, StudyKIK
With eight years in the clinical trial industry, Zack Metcalf, Senior Director of Global Business Solutions at StudyKIK has been a driving force in supporting pharmaceutical companies’ quest to bring treatments to market faster for patients across various therapeutic areas. A visionary leader, Zack has led groundbreaking efforts in patient recruitment, patient retention, and the implementation of diversity solutions at StudyKIK, looking to reshape the industry landscape. Zack continues to be a catalyst for innovative change, ensuring that StudyKIK remains at the forefront of revolutionizing the clinical trial experience.
Who Should Attend?
This webinar will be of interest to pharmaceutical C-suite, VP, Directors and site personnel in the following department and/or job titles:
- Clinical development
- Clinical research
- Digital innovation
- Decentralized trials
- Patient solutions
- Patient engagement
- Clinical operations
What You Will Learn
Attendees will gain insights into:
- Where the industry is in the AD space, what impact has been made in the last 20 years and what the near future looks like
- The multifaceted strategy for promoting diversity within Alzheimer’s disease clinical research, including the use of medical record examinations and diverse identification tactics
- The role of innovation in tracking progress and education on underrepresented patient populations and the non-linear nature of the path to solutions
- How the comprehensive approach discussed encapsulates the principles of diversity, equity and inclusion (DE&I), and serves as a model for advancing equitable access to Alzheimer’s clinical research
StudyKIK, a Syneos Health Company, is at the forefront of clinical trial management technologies, specializing in innovative solutions for patient recruitment and retention. Since its establishment in 2014, StudyKIK has been dedicated to enhancing and optimizing the clinical trial lifecycle, redefining the experience for patients, sites and sponsors alike.